Findings from Cardiovascular Evaluation of NCAA Division I Collegiate Student-Athletes after Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection
Calvin E Hwang, Andrea Kussman, Jeffrey W Christle, Victor Froelicher, Matthew T Wheeler, Kegan J Moneghetti
doi: https://doi.org/10.1101/2021.01.07.21249407
Calvin E Hwang
1Department of Orthopaedic Surgery, Division of Sports Medicine, Stanford University, Palo Alto, CA, USA
MDAndrea Kussman
1Department of Orthopaedic Surgery, Division of Sports Medicine, Stanford University, Palo Alto, CA, USA
MDJeffrey W Christle
2Department of Medicine, Division of Cardiovascular Medicine, Sports Cardiology Clinic, Stanford University, Palo Alto, CA, USA
PhDVictor Froelicher
2Department of Medicine, Division of Cardiovascular Medicine, Sports Cardiology Clinic, Stanford University, Palo Alto, CA, USA
MDMatthew T Wheeler
2Department of Medicine, Division of Cardiovascular Medicine, Sports Cardiology Clinic, Stanford University, Palo Alto, CA, USA
MD PhDKegan J Moneghetti
2Department of Medicine, Division of Cardiovascular Medicine, Sports Cardiology Clinic, Stanford University, Palo Alto, CA, USA
MBBS (hons)Data Availability
Data are available upon reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information. Deidentified participant data are available in a database held by Stanford University School of Medicine. They are not available for reuse. Additional information can be requested by contacting the corresponding author (highlndr@stanford.edu).
Posted January 08, 2021.
Findings from Cardiovascular Evaluation of NCAA Division I Collegiate Student-Athletes after Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection
Calvin E Hwang, Andrea Kussman, Jeffrey W Christle, Victor Froelicher, Matthew T Wheeler, Kegan J Moneghetti
medRxiv 2021.01.07.21249407; doi: https://doi.org/10.1101/2021.01.07.21249407
Findings from Cardiovascular Evaluation of NCAA Division I Collegiate Student-Athletes after Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection
Calvin E Hwang, Andrea Kussman, Jeffrey W Christle, Victor Froelicher, Matthew T Wheeler, Kegan J Moneghetti
medRxiv 2021.01.07.21249407; doi: https://doi.org/10.1101/2021.01.07.21249407
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2977)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12836)
- Forensic Medicine (12)
- Gastroenterology (835)
- Genetic and Genomic Medicine (4636)
- Geriatric Medicine (426)
- Health Economics (733)
- Health Informatics (2951)
- Health Policy (1075)
- Hematology (394)
- HIV/AIDS (936)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4429)
- Nursing (238)
- Nutrition (653)
- Oncology (2301)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (504)
- Public and Global Health (7024)
- Radiology and Imaging (1556)
- Respiratory Medicine (924)
- Rheumatology (447)
- Sports Medicine (386)
- Surgery (493)
- Toxicology (60)
- Transplantation (213)
- Urology (185)